Market Overview:
The global G protein coupled bile acid receptor 1 market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and growing demand for novel therapeutics. By type, INT-777 is expected to account for the largest share of the market in 2018. By application, diarrhea is expected to account for the largest share of the market in 2018. North America is estimated to dominate the global G protein coupled bile acid receptor 1 market in terms of revenue in 2018.
Product Definition:
G Protein Coupled Bile Acid Receptor 1 is a receptor protein that is found on the surface of cells. It binds to bile acids and causes a change in the cell's activity. The importance of G Protein Coupled Bile Acid Receptor 1 is not fully understood, but it may play a role in regulating lipid metabolism and inflammation.
INT-777:
The G protein-coupled bile acid receptor 1 (GPR1) is a type of receptor found in the gastrointestinal tract and is responsible for detecting bile acids. Bile acids are organic compounds that are naturally present in the body, but can also be manufactured by the liver from cholesterol.
RDX-98940:
RDX-98940 is a novel, Potent and selective (Ki = 0.4 nM) small molecule GPCR modulator that was developed as an ARF inhibitor for the treatment of cancer by targeting mTORC1. It has been found to have higher efficacy than currently available drugs in preclinical models of cancer with reduced side effects at doses as low as 1 mg/kg.
Application Insights:
Diarrhea was the most prominent application of G protein coupled bile acid receptor 1 in the global market. The drug is under clinical investigation for the treatment of chronic diarrhea. However, extensive research is required to develop this receptor as a therapeutic target in chronic diarrhea due to low binding affinity and specificity.
Bile acids play an important role in fat digestion by enhancing intestinal absorption of cholesterol along with other fatty acids from dietary sources such as eggs and meat products among others which results in reduced serum levels of total cholesterol (TC) amongst patients suffering from dyslipidemia compared with healthy individuals who do not suffer from any type of liver or gallbladder disorders or take any medication whatsoever.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing R&D investments by major companies and rising adoption of gout therapies in U.S. Moreover, presence of key players such as Pfizer Inc.; Merck & Co., Inc.; and Sanofi are contributing towards growth of this regional market.
Asia Pacific is anticipated to witness lucrative CAGR over the forecast period owing to growing healthcare expenditure, improving economic conditions, increase in disposable income levels coupled with rise in consumer awareness regarding available treatment options for gout attacks. In addition, availability of generic drugs for off-label uses may contribute towards growth over the coming years (Ref).
Growth Factors:
- Increasing prevalence of obesity and metabolic syndrome
- Rising geriatric population
- Growing demand for novel therapeutics for the treatment of various diseases
- Technological advancements in the field of bile acid research
- increasing investment by pharmaceutical companies in R&D for novel bile acid therapies
Scope Of The Report
Report Attributes
Report Details
Report Title
G Protein Coupled Bile Acid Receptor 1 Market Research Report
By Type
INT-777, RDX-98940, S-0071261, Others
By Application
Diarrhea, Dyslipidemia, Kidney Fibrosis, Others
By Companies
Ardelyx Inc, Intercept Pharmaceuticals Inc, Torrent Pharmaceuticals Ltd, Ardelyx Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
205
Number of Tables & Figures
144
Customization Available
Yes, the report can be customized as per your need.
Global G Protein Coupled Bile Acid Receptor 1 Market Report Segments:
The global G Protein Coupled Bile Acid Receptor 1 market is segmented on the basis of:
Types
INT-777, RDX-98940, S-0071261, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diarrhea, Dyslipidemia, Kidney Fibrosis, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ardelyx Inc
- Intercept Pharmaceuticals Inc
- Torrent Pharmaceuticals Ltd
- Ardelyx Inc
Highlights of The G Protein Coupled Bile Acid Receptor 1 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- INT-777
- RDX-98940
- S-0071261
- Others
- By Application:
- Diarrhea
- Dyslipidemia
- Kidney Fibrosis
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the G Protein Coupled Bile Acid Receptor 1 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
G protein coupled bile acid receptor 1 is a type of receptor that binds to bile acids. Bile acids are chemicals that are produced by the liver and help to break down food.
Some of the major companies in the g protein coupled bile acid receptor 1 market are Ardelyx Inc, Intercept Pharmaceuticals Inc, Torrent Pharmaceuticals Ltd, Ardelyx Inc.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 G Protein Coupled Bile Acid Receptor 1 Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 G Protein Coupled Bile Acid Receptor 1 Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 G Protein Coupled Bile Acid Receptor 1 Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the G Protein Coupled Bile Acid Receptor 1 Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global G Protein Coupled Bile Acid Receptor 1 Market Size & Forecast, 2020-2028
4.5.1 G Protein Coupled Bile Acid Receptor 1 Market Size and Y-o-Y Growth
4.5.2 G Protein Coupled Bile Acid Receptor 1 Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 INT-777
5.2.2 RDX-98940
5.2.3 S-0071261
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Diarrhea
6.2.2 Dyslipidemia
6.2.3 Kidney Fibrosis
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global G Protein Coupled Bile Acid Receptor 1 Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 G Protein Coupled Bile Acid Receptor 1 Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 INT-777
9.6.2 RDX-98940
9.6.3 S-0071261
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Diarrhea
9.10.2 Dyslipidemia
9.10.3 Kidney Fibrosis
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 INT-777
10.6.2 RDX-98940
10.6.3 S-0071261
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Diarrhea
10.10.2 Dyslipidemia
10.10.3 Kidney Fibrosis
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 INT-777
11.6.2 RDX-98940
11.6.3 S-0071261
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Diarrhea
11.10.2 Dyslipidemia
11.10.3 Kidney Fibrosis
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 INT-777
12.6.2 RDX-98940
12.6.3 S-0071261
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Diarrhea
12.10.2 Dyslipidemia
12.10.3 Kidney Fibrosis
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 INT-777
13.6.2 RDX-98940
13.6.3 S-0071261
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Diarrhea
13.10.2 Dyslipidemia
13.10.3 Kidney Fibrosis
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 G Protein Coupled Bile Acid Receptor 1 Market: Competitive Dashboard
14.2 Global G Protein Coupled Bile Acid Receptor 1 Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ardelyx Inc
14.3.2 Intercept Pharmaceuticals Inc
14.3.3 Torrent Pharmaceuticals Ltd
14.3.4 Ardelyx Inc
